Supervised Outdoor-Use Test to Assess the Safety of a Sunscreen C-Spray on Sport Users
NCT ID: NCT02857478
Last Updated: 2018-12-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
98 participants
INTERVENTIONAL
2015-06-27
2015-06-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Safety of a Sunscreen product
Sunscreen product safety evaluation under supervised out-door conditions on sport users.
BAY 987519, SPF 50, Y51-002
Sufficient amount to cover all exposed skin liberally two times - approximately 240 min.
BAY 987519, SPF 50, P04-147
Sufficient amount to cover all exposed skin liberally two times - approximately 240 min.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
BAY 987519, SPF 50, Y51-002
Sufficient amount to cover all exposed skin liberally two times - approximately 240 min.
BAY 987519, SPF 50, P04-147
Sufficient amount to cover all exposed skin liberally two times - approximately 240 min.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No actinic keratosis, skin cancer, psoriasis, eczema, or any other acute or chronic skin conditions
* Must not have visible erythema, blistering or peeling that would indicate recent sunburn
* Must not have asthma. Must not be undergoing therapy with system or topical corticosteroids, anti-inflammatories or antihistamine agents
* Must not be taking any medication in which exposure to the sun is contraindicated
* Must be willing to obey all rules of the test facility
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bayer
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bayer Study Director
Role: STUDY_DIRECTOR
Bayer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
St. Petersburg, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
18317
Identifier Type: -
Identifier Source: org_study_id